Acceptance Tests and Quality Control of the Positron Emission Tomography (PET) Systems
Journal Title: Nuclear Medicine Seminars - Year 2020, Vol 6, Issue 2
Abstract
Quality control (QC) applications are important for the reliability and accuracy of the results obtained from positron emission tomography (PET) imaging systems in clinical trials. With these applications, exposure of patients and employees to more radiation will be prevented, and it will be possible to detect the systems that lost their performance compared to their installation time. QC applications are grouped as acceptance and reference tests, routine periodic QC tests. PET performance tests standardized by National Electrical Manufacturers Association (NEMA) should be used as acceptance and reference tests. In addition, the performance of the device should be monitored by following these tests at six-month intervals. PET/computerized tomography (CT) manufacturers often recommend routine QC procedures for their equipment and require users to follow these recommendations to a minimum. If standards are not defined for routine QC procedures, it is recommended to comply with the general minimum standards for routine QC that all PET/CT centers must perform. Routine QC protocols, the image quality of the PET system; CT image quality and CT dose of the patient; the accuracy of CT-based attenuation corrections; the accuracy of the CT and PET co-registration should ensure that problems that can interact any of the performance characteristics are identified. Since performing PET/CT scans by equipment that does not comply with their specifications may compromise image quality, interpretation of images and reliability of results, daily QC parameters must be evaluated and necessary corrective procedures must be taken prior to scanning. The tests are carried out using the protocol provided by the manufacturer.
Authors and Affiliations
Tuğba Hacıosmanoğlu, Mustafa Demir, Türkay Toklu, F. Suna Kıraç, Mehmet İnce, Yasemin Parlak, Bilal Kovan, Semra Dönmez, Aslı Ayan, İnci Alıç Özaslan, Meral Hiçürkmez, Nami Yeyin, Leyla Poyraz ve TNTD Kalite kontrol ve Radyasyon Güvenliği çalışma grubu üyeleri
Keywords
Related Articles
- EP ID EP688741
- DOI 10.4274/nts.galenos.2020.0008
- Views 199
- Downloads 0
The Role of Nuclear Medicine in Pediatric Hydronephrosis
Nuclear medicine studies are non-invasive, simple, functional diagnostic investigations that can be used in all ages of childhood even in the neonatal period. While dynamic renal scintigraphy has been a well-established...
Radionuclide Methods for Pain Palliation
Bone is a common metastatic site of cancer. Bone metastasis reduces life expectancy and results in serious symptoms and complications such as bone pain, pathological fractures, spinal cord compression, and malignant hype...
Guidelines for Myocardial Viability Imaging with F-18 FDG
Myocardial viability imaging with Fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT), in patients who are appropriate for coronary revascularization, in the presence of le...
Nuclear Medicine in Urinary Tract İnfection
Urinary tract infections (UTIs) are frequent in pediatric population and have various clinical presentations. Definitive diagnosis is made by urinalysis and quantitative urine culture, and antibiotic treatment is usually...
Good Radiopharmacy Practices In Magistral (or Inhouse or Smallscale) Produced Radiopharmaceuticals
Radiopharmaceuticals differ from normal medicines in that they have a short half-life. Due to the rapid decay, they must be prepared shortly before their clinical use and comprehensive quality control of the final produc...